D
J. Shang et al.
ArH), 7.13 (2H, m, ArH), 4.96 (2H, s, CH2), 2.41 (6H, s, 2Me).
dC (100 MHz, CDCl3) 173.6, 136.6, 128.6, 127.3, 125.8, 47.4,
26.4. m/z (ESI) 192 ([M þ H]þ, 100 %). HRMS m/z 192.1206;
calcd for C11H13NO2 192.1019. nmax (CHCl3)/cmꢀ1 3032, 1695,
1606, 1497, 1370, 1267, 1208, 975, 872, 717, 694.
calcd for C20H23NO3 326.1751. nmax (CHCl3)/cmꢀ1 2968, 2927,
1673, 1602, 1245, 1164.
N-Acetyl-N-benzyl-2,4-dimethoxybenzamide (13ah)
N-Benzyl-2,4-dimethoxythiobenzamide
(11h)
(83.2 mg,
0.3 mmol) and acetic acid (12a) (8.2 mL, 0.15 mmol) were
treated according to general procedure A to give the product
13ah (40.8 mg, 89 %) as a white solid. dH (400 MHz, CDCl3)
7.33–7.18 (8H, m, ArH), 4.92 (2H, s, CH2), 3.83 (3H, s, p-OMe),
3.75 (3H, s, o-OMe), 2.24 (3H, s, Me). dC (100 MHz, CDCl3)
173.4, 171.5, 163.6, 157.9, 137.8, 131.5, 128.3, 127.8, 127.1,
118.5, 105.1, 98.5, 55.6, 55.5, 48.6, 25.9. m/z (ESI) 314
([M þ H]þ, 100 %). HRMS m/z 314.1376; calcd for C18H19NO4
314.1387. nmax (CHCl3)/cmꢀ1 3007, 2970, 2941, 2841, 1698,
1648, 1606, 1210, 1164, 978.
N-Acetyl-N-benzylpivalamide (13ab)[13]
N-Benzylthiopivalamide 11b (80.0 mg, 0.4 mmol) and acetic
acid (11 mL, 0.2 mmol) were treated according to general pro-
cedure A to give the imide 13ab (37 mg, 82 %) as a colourless
oil. dH (400 MHz, CDCl3) 7.33–7.18 (5H, m, ArH), 4.83 (2H, s,
CH2), 2.22 (3H, s, Me), 1.25 (9H, s, tBu). dC (100 MHz, CDCl3)
187.5, 173.2, 137.2, 128.7, 127.4, 126.7, 49.1, 43.2, 28.1, 24.4;
MS (ESI) m/z: 234 ([M þ H]þ, 100 %). HRMS m/z 234.1417;
calcd for C14H19NO2 234.1489. nmax (CHCl3)/cmꢀ1 3304, 2966,
2928, 1676, 1373, 1336, 1159, 975, 733, 699.
N-Benzyl-N-pivaloyl-2,4-dimethoxybenzamide (13bh)
N-Acetyl-N-benzylbenzamide (13af)[14,15]
N-Benzyl-2,4-dimethoxythiobenzamide
(11h)
(85.2 mg,
N-Benzylthiobenzamide (11f) (71 mg, 0.3 mmol) and acetic
acid (12a) (8.2 mL, 0.15 mmol) were treated according to general
procedure A to give the product 13af (39 mg, 88 %) as a col-
ourless oil. dH (400 MHz, CDCl3) 7.56–7.22 (10H, m, ArH),
5.00 (2H, s, CH2), 2.16 (3H, s, Me). dC (100 MHz, CDCl3) 174.3,
173.2, 137.3, 135.8, 132.4, 128.8, 128.5, 128.4, 127.8, 127.4,
49.3, 26.4. m/z (ESI) 254 ([M þ H]þ, 100 %). HRMS m/z
254.1201; calcd for C16H15NO2 254.1176. nmax (CHCl3)/cmꢀ1
3031, 2971, 1686, 1659, 1215, 727, 696.
0.3 mmol) and pivalic acid (12b) (17.2 mL, 0.15 mmol) were
treated according to general procedure A to give the product
13bh (41.5 mg, 83 %) as a white solid. dH (400 MHz, CDCl3)
7.33–7.15 (6H, m, ArH), 6.48–6.44 (2H, m, ArH), 4.70 (2H, s,
CH2), 3.83 (3H, s, OMe), 3.79 (3H, s, OMe), 1.24 (9H, s, tBu).
dC (400 MHz, CDCl3) 187.4, 172.0, 163.5, 158.3, 137.7, 132.1,
128.2, 127.7, 127.1, 117.8, 104.9, 98.6, 55.5, 51.1, 43.4, 28.4.
m/z (ESI) 356 ([M þ H]þ, 100 %). HRMS m/z 356.1875; calcd
for C21H25NO4 356.1856. nmax (CHCl3)/cmꢀ1 3402, 3063,
3029, 3005, 2925, 2852, 1642, 1603, 1528, 1496, 1295, 1208,
1166, 1025, 699.
N-Benzyl-N-pivaloylbenzamide (13bf)[16]
N-Benzylthiobenzamide (11f) (85 mg, 0.3 mmol) and pivalic
acid (12b) (22.6 mL, 0.2 mmol) were treated according to gen-
eral procedure A to give the product 13bf (36.4 mg, 71.5 %) as a
white solid. dH (400 MHz, CDCl3) 7.69–7.20 (10H, m, ArH),
4.83 (2H, s, CH2), 1.21 (9H, s, tBu). dC (100 MHz, CDCl3)
187.4, 174.8, 137.2, 135.0, 132.5, 129.0, 128.7, 128.5, 127.7,
127.4, 51.3, 43.5, 28.5. m/z (ESI) 296 ([M þ H]þ, 100 %).
HRMS m/z 296.1653; calcd for C19H21NO2 296.1645. nmax
(CHCl3)/cmꢀ1 3065, 3031, 2970, 2924, 1676, 1655, 1342, 1239,
1167, 1125, 965, 721, 696.
N-Acetyl-N-benzyl-4-nitrobenzamide (13ai)
N-Benzyl-4-nitrothiobenzamide (11i) (101 mg, 0.35 mmol) and
acetic acid (12a) (11.1 mL, 0.2 mmol) were treated according to
general procedure A to give the product 13ai (38 mg, 70 %) as a
yellow solid. dH (400 MHz, CDCl3) 8.26–7.16 (9H, m, ArH),
4.99 (2H, s, CH2), 2.31 (3H, s, Me). dC (100 MHz, CDCl3) 173.1,
172.2, 149.4, 141.7, 136.5, 128.9, 128.6, 127.8, 127.1, 123.8,
49.1, 26.0. nmax (CHCl3)/cmꢀ1 3108, 3066, 3030, 2971, 2865,
1686, 1664, 1604, 1522, 1345, 1211.
N-Acetyl-N-benzyl-4-methoxybenzamide (13ag)[15]
N-Benzyl-N-pivaloyl-4-nitrobenzamide (13bi)
N-Benzyl-4-nitrothiobenzamide (11i) (103 mg, 0.4 mmol) and
pivalic acid (12b) (22.5 mL, 0.2 mmol) were treated according to
general procedure A to give the product 13bi (25.2 mg, 50 %) as
a yellow solid. dH (400 MHz, CDCl3) 8.20–7.08 (9H, m, ArH),
4.80 (2H, s, CH2), 1.19 (9H, s, tBu). dC (100 MHz, CDCl3)
186.9, 172.5, 149.5, 140.9, 136.5, 129.2, 128.8, 127.7, 127.1,
123.9, 50.6, 43.3, 28.4. nmax (CHCl3)/cmꢀ1 3316, 3030, 2971,
2927, 1738, 1644, 1600, 1523, 1247.
N-Benzyl-4-methoxythiobenzamide (11g) (70.2 mg, 0.3 mmol)
and acetic acid (12a) (8.2 mL, 0.15 mmol) were treated accord-
ing to general procedure A to give the product 13ag (39.6 mg,
92 %) as a colourless oil. dH (400 MHz, CDCl3) 7.58–6.90 (9H,
m, ArH), 5.00 (2H, s, CH2), 3.85 (3H, s, OMe), 2.11 (3H, s, Me).
dC (100 MHz, CDCl3) 173.9, 173.0, 163.3, 137.4, 131.1, 128.5,
127.9, 127.7, 127.4, 114.1, 55.5, 49.5, 26.1. m/z (ESI) 284
([M þ H]þ, 100 %). HRMS m/z 284.1287; calcd for C17H17NO3
284.1281. nmax (CHCl3)/cmꢀ1 3030, 2971, 2938, 1682, 1655,
1602, 1256, 1217, 1167, 1026, 844, 699.
N-Acetyl-N-benzyl-2,4-dinitrobenzamide (13aj)
N-Benzyl-2,4-dinitrothiobenzamide (11j) (63 mg, 0.2 mmol)
and acetic acid (12a) (6.0 mL, 0.1 mmol) were treated according
to general procedure A to give the product 13aj (32 mg, 41 %)
as a light yellow oil. dH (400 MHz, CDCl3) 9.08–9.06 (1H, m,
ArH), 8.51–8.48 (1H, m, ArH), 7.43–7.24 (6H, m, ArH), 5.14
(2H, s, CH2), 2.26 (3H, s, Me).
N-Benzyl-N-pivaloyl-4-methoxybenzamide (13bg)[16]
N-Benzyl-4-methoxythiobenzamide (11g) (48.5 mg, 0.2 mmol)
and pivalic acid (12b) (11.6 mL, 0.1 mmol) were treated
according to general procedure A to give the product 13bg
(27.4 mg, 84 %) as a white solid. dH (400 MHz, CDCl3) 7.70–
6.90 (9H, m, ArH), 4.83 (2H, s, CH2), 3.68 (3H, s, OMe), 1.21
(9H, s, tBu). dC (100 MHz, CDCl3) 186.7, 174.4, 163.3, 137.4,
131.5, 128.5, 127.6, 127.3, 127.0, 114.1, 55.5, 51.5, 43.3, 28.6.
m/z (ESI) 326 ([M þ H]þ, 100 %). HRMS m/z 326.1747;
General Procedure B
To a solution of imide 13 (0.3 mmol) in 1 : 1 dioxane/H2O
(6 mL) was added LiOHꢁH2O (41 mg, 0.9 mmol) and the